White Paper
Combination Therapy Dose Optimization in Oncology Trials
Design, modeling, and operational considerations for biotech and pharma
May 16, 2025
Combination therapies represent the future of oncology innovation, offering clinicians with regimens that have the potential to enhance efficacy, delay resistance and improve patients' responses and outcomes. Yet, determining dose optimization for such regimens is among the field's most complex challenges and requires rigorous operational and statistical planning and execution. This white paper reviews the design, operational, and analytic challenges that sponsors must consider when designing effective and efficient combination dose-finding trials. Sponsors who partner with clinical research organizations like IQVIA can leverage their experience in this setting to realize precision and efficiencies to advance combination therapies aligned with global regulatory expectations.

Related solutions

Contact Us